GCM
MRK icon

Genus Capital Management’s Merck MRK Stock Holding History

Genus Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,479
Closed -$446K – 299
2024
Q4 		$446K Sell
4,479
-54,112
-92% -$5.58M 0.06% 144
2024
Q3 		$6.65M Sell
58,591
-92,782
-61% -$11M 0.87% 36
2024
Q2 		$18.7M Buy
+151,373
New +$19.5M 2.47% 2
2024
Q1 		– Sell
-174,013
Closed -$19M – 325
2023
Q4 		$19M Buy
+174,013
New +$18.1M 2.78% 5

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Genus Capital Management's MRK Position: Q2 2026 in Review

Genus Capital Management reduced its Merck (MRK) stake by 78% in Q2 2026, selling an estimated $9.4M and leaving 22,719 shares worth $2.92M. The position accounts for 0.29% of the portfolio, ranked #95.

Genus Capital Management first reported a position in MRK in Q2 2023 and has held it in 8 quarters since. The position peaked at $22.4M in Q1 2024. 3,847 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Genus Capital Management held 22,719 shares of Merck worth $2.92M as of Q2 2026.
  • Genus Capital Management sold 80,267 Merck shares in Q2 2026, an estimated $9.4M.
  • Merck made up 0.29% of Genus Capital Management's portfolio in Q2 2026, its #95 holding.
  • Genus Capital Management first reported a position in Merck in Q2 2023 and has held it in 8 quarters since.
  • Genus Capital Management's Merck position peaked at $22.4M in Q1 2024.
  • 3,847 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Genus Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.